COLORADO: CW Hemp, makers of the world-renowned Charlotte’s Web™ hemp extract oils with cannabinoids, announced today the launch of their CW™ SiMPLY line of capsule products. “CW SiMPLY was created to make it easier for our busy customers to integrate Charlotte’s Web into their daily routines,” said Ashley Grace, Chief Marketing and e-Commerce Officer for CW Hemp. “Charlotte’s Web Hemp oils have been long trusted for their superior hemp genetics and industry-leading quality. We are thrilled to extend this trust in the form of a convenient, user-friendly capsule.”
Two products, CW SiMPLY Hemp with 15mg of Charlotte’s Web Hemp extract per capsule, and CW SiMPLY Hemp+Extra with 35mg per capsule, will initially comprise the line. Each product will be available in 30 and 60-count offerings. Additional CW SiMPLY products are planned for early 2017.
The CW SiMPLY line of products features proprietary Charlotte’s Web hemp genetics drawn from all over the world and refined over several years of tireless breeding by Colorado’s Stanley Brothers. Charlotte’s Web hemp is organically grown on Colorado family farms and the oil is manufactured in an FDA registered facility in Boulder according to Good Manufacturing Practices.
After gaining global celebrity as the “low-THC medical marijuana” product first used by Charlotte Figi in Sanjay Gupta’s CNN documentaries, the 2014 US Farm bill enabled Charlotte’s Web to be classified as “industrial hemp” and opened doors for the company to serve a variety of wellness needs under its purpose to empower a better quality of life. To that end, CW Hemp donates a portion of sales to the Realm of Caring (RoC), who is working with Johns Hopkins University and others to research the potential impact cannabinoids could have on inflammatory conditions such as anxiety, chronic pain, diabetes, brain trauma, and many others.
“Hemp is non-psychoactive and has been used for a wide variety of wellness needs with no observed side-effects for thousands of years. We’re excited to make Charlotte’s Web available in the more common supplement form of a capsule,” said Grace. “While we are clear in making no claims about our products, the US government actually owns patent 6630507 which documents cannabinoids potential application for many inflammatory conditions. We encourage people to do their own research by searching for #WHYCW.”